Literature DB >> 25383850

Intravitreal triamcinolone acetonide treatment of tamoxifen maculopathy with associated cystoid macular edema.

Karen W Jeng1, H Matthew Wheatley.   

Abstract

PURPOSE: To report a case of severe tamoxifen-induced maculopathy with associated cystoid macular edema treated with intravitreal triamcinolone acetonide.
METHODS: Case report.
RESULTS: The patient presented with bilateral cystoid macular edema that persisted despite treatment, which included intravitreal bevacizumab injections. He received 7 triamcinolone injections in each eye over 20 months, resulting in the most recent best-corrected Snellen visual acuities of 20/40 in the right eye and 20/30 in the left eye. Complete resolution of the cystoid macular edema was achieved in each eye, but recurrent edema necessitated continued intermittent injections. Macular crystals persisted despite treatment but decreased since presentation.
CONCLUSION: Intravitreal triamcinolone should be considered for treatment of tamoxifen-associated macular edema, especially if the condition responds poorly to anti-vascular endothelial growth factor treatments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25383850     DOI: 10.1097/ICB.0000000000000093

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient.

Authors:  Chuanyu Li; Jun Xiao; He Zou; Bo Yang; Lifu Luo
Journal:  BMC Ophthalmol       Date:  2021-05-07       Impact factor: 2.209

2.  Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.

Authors:  Akihiro Shinkai; Wataru Saito; Yuki Hashimoto; Susumu Ishida
Journal:  BMC Ophthalmol       Date:  2019-12-30       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.